Abstract: A transport container is configured to capture air bubbles remaining in a container with a simple mechanism and a simple operation to protect a graft. The transport container includes: a lid that seals a container for housing a graft, in which the lid has a protrusion protruding toward a space inside the container in a state of being attached to the container. A substantially annular groove is formed on a lower surface of the protrusion. Gas and liquid inside the container housing the graft and liquid are pushed out by the lid to achieve a liquid-tight state, and air bubbles in the liquid can be captured in the groove on the lower surface.

Abstract: A container is disclosed for isolating living cells. The container for crushing a sample by pressing includes a container main body having an opening part and a partition which separates an upper space and a lower space of the container main body, in which at least a part of the partition has a portion which is not horizontal with respect to the bottom of the container.

Abstract: A method for enhancing activity selected from the group consisting of cytokine production capacity, proliferation capacity, engraftment capacity, angiogenesis-inducing capacity, and tissue regeneration capacity in a graft, particularly in a sheet-shaped cell culture containing a somatic cell, involves incubating the graft at a temperature of 25° C. or higher.

Abstract: An automatic analysis apparatus of an embodiment includes a holder, a first dispenser, a second dispenser, a detector, a memory, and processing circuitry. The holder movably holds a plurality of reaction vessels. The first dispenser dispenses an analyte into each of the reaction vessels. The second dispenser dispenses a reagent into the reaction vessel. The detector detects light transmitted through the reaction vessel. The memory stores a test order. The processing circuitry controls the holder, the first dispenser, and the second dispenser based on the test order. The processing circuitry determines one of the reaction vessels to be used for measuring the analyte based on the test order, and performs control to collect characteristic data from another of the reaction vessels not used for measuring the analyte while the analyte is measured.

Abstract: The present invention provides a triazole compound of the following formula: a prodrug thereof or a pharmaceutically acceptable salt thereof. The above-mentioned triazole compound has superior HSD1 inhibitory activity, and is useful as an HSD1 inhibitor, a therapeutic drug of diabetes or a therapeutic drug of obesity or a therapeutic drug of metabolic syndrome.

Abstract: The present invention provides a triazole compound of the following formula: a prodrug thereof or a pharmaceutically acceptable salt thereof. The above-mentioned triazole compound is useful as a therapeutic drug for the treatment of diabetes, obesity or metabolic syndrome.

Abstract: The present invention provides a triazole compound of the following formula: a prodrug thereof or a pharmaceutically acceptable salt thereof. The above-mentioned triazole compound has superior HSD1 inhibitory activity, and is useful as an HSD1 inhibitor, a therapeutic drug of diabetes or a therapeutic drug of obesity or a therapeutic drug of metabolic syndrome.

Abstract: The pyrazole compound of the present invention is represented by the following general formula (I). The pyrazole compound of the present invention or a salt thereof or a solvate thereof potently inhibits liver glycogen phosphorylase, and, therefore, is useful as a therapeutic or prophylactic agent for diabetes. wherein each symbol denotes as described in the specifications.

Abstract: The present invention provides a triazole compound of the following formula: a prodrug thereof or a pharmaceutically acceptable salt thereof. The above-mentioned triazole compound is useful as a therapeutic drug for the treatment of diabetes, obesity or metabolic syndrome.

Abstract: The present invention provides a pyrazole compound that has liver glycogen phosphorylase inhibitory activity and is useful as a therapeutic or prophylactic agent for diabetes, the pyrazole compound represented by the following general formula (I): wherein Ring Q represents an aryl or heteroaromatic group, R1 represents a hydrogen atom, a halogen atom, a C1-6 alkyl group or a C1-6 alkoxy group, R2 represents a halogen atom, a C1-6 alkyl group, a C1-6 alkoxy group or an azido group, R3 represents a halogen atom, a hydroxyl group, a C1-6 alkyl group, a halo C1-6 alkyl group, a C1-6 alkoxy group, an azido group, an amino group, an acylamino group or a C1-6 alkylsulfonylamino group, R4 and R5 are identical with or different from each other and represent a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a C3-8 cycloalkyl group, a substituted or unsubstituted saturated heterocyclic group, a substituted or unsubstituted aryl group, a C7-14 aralkyl group, a heteroaromatic group, or the like, or

Abstract: A fixed blade and a rotary cutter are mounted in a supporting frame of a wire cutting apparatus. A clearance not larger than a half of a diameter of the wire is provided between a tip of the fixed blade and a tip of the rotary cutter. The rotary cutter has a channel provided between each couple of cutting edges of the rotary cutter and inclined to its rotational shaft. The fixed blade may be disposed in each of opposing side walls of the supporting frame, the fixed blades being shifted from each other in an axial direction of the rotational shaft.

Abstract: A wire guide apparatus for the wire electrode electric spark forming machine utilizes the flow of compressed air for feeding the used wire into a cutting apparatus that is operated in combination with the wire guide apparatus. The wire guide apparatus includes a guide tube 1 for taking in the used wire from the electric spark forming machine and a compressed air supply section 2. The guide tube 1 has a funnel-shaped wire introducing port 3 formed at the upper end and a wire discharge port at the lower end. The compressed air is injected into the guide tube 1 from the fluid injection path 5 formed in the circumferential wall 1a of the guide tube to smoothly guide the wire 12 from the wire introducing port 3 to the outside of the wire discharge port 4.

Abstract: An elongate object cutting apparatus which can cut an elongate object finely and at a high speed while production of vibrations or noises is reduced is disclosed. The elongate object cutting apparatus is suitably used to cut a flexible elongate object such as a terminal carrier having a plurality of terminals connected in the form of a chain in a process of manufacturing a wire harness or a wire or an electric wire for use with a wire electrode electric discharge machine, into small pieces. The elongate object cutting apparatus comprises a fixed blade secured to a frame, a rotary blade having a plurality of knife edges on an outer periphery thereof and mounted for rotation on the frame such that the knife edges thereof successively contact with the fixed blade during rotation thereof. While the rotary blade is rotated, an elongate object is supplied between and cut by cooperation of the fixed blade and the rotary blade.

Abstract: A display element is rotatably mounted and has a surface portion which includes a nontransparent area and a transparent area, and these two areas are different colors than each other. Such element is mounted behind a front panel having an opening facing the element. By controlling the rotational position of the display element, one of above described areas is selectively displayed. The transparent area can be positioned partly inside and partly outside the front panel, and light from a light source provided inside the front panel can be scattered through the display element.